Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Goodwill (2020 - 2025)

Historic Goodwill for Northwest Biotherapeutics (NWBO) over the last 8 years, with Q3 2025 value amounting to $626000.0.

  • Northwest Biotherapeutics' Goodwill changed 0.0% to $626000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $626000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $626000.0 for FY2024, which is 0.0% changed from last year.
  • Northwest Biotherapeutics' Goodwill amounted to $626000.0 in Q3 2025, which was down 0.0% from $626000.0 recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Goodwill ranged from a high of $626000.0 in Q1 2021 and a low of $626000.0 during Q1 2021
  • In the last 5 years, Northwest Biotherapeutics' Goodwill had a median value of $626000.0 in 2021 and averaged $626000.0.
  • Examining YoY changes over the last 5 years, Northwest Biotherapeutics' Goodwill showed a top increase of 0.0% in 2021 and a maximum decrease of 428.13% in 2021.
  • Northwest Biotherapeutics' Goodwill (Quarter) stood at $626000.0 in 2021, then changed by 0.0% to $626000.0 in 2022, then changed by 0.0% to $626000.0 in 2023, then changed by 0.0% to $626000.0 in 2024, then changed by 0.0% to $626000.0 in 2025.
  • Its Goodwill was $626000.0 in Q3 2025, compared to $626000.0 in Q2 2025 and $626000.0 in Q1 2025.